MARGARET COE: Open Payments
NPI 1366997520 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,103 in 118 payments from 23 companies in 2025. Trend: 2023 $2,846 · 2024 $2,169 · 2025 $2,103
Food & beverage: $2,073Education: $30
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $283 |
| ABBVIE INC. | 17 | $283 |
| Vanda Pharmaceuticals Inc. | 15 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $200 |
| AstraZeneca Pharmaceuticals LP | 6 | $171 |
| Otsuka America Pharmaceutical, Inc. | 9 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $134 |
| Amgen Inc. | 7 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Novo Nordisk Inc | 4 | $79 |
Products named: FANAPT, CAPLYTA, REXULTI, NURTEC ODT, QULIPTA, Kerendia, VRAYLAR, FARXIGA.
Industry payments across MI — which companies pay providers there.
